Shire gets US approval for key drug Shire Pharmaceuticals has won US regulatory approval for its long-delayed Fosrenol treatment for severe kidney disease. Fosrenol is Shire #39;s SHP. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 